Valuation: Healius Limited

Market Cap 272M 190M 166M 153M 141M 266M 18.3B 1.83B 721M 8.97B 714M 698M 30.88B P/E 2026 *
-9.87x
P/E 2027 * -105x
Enterprise Value 1.18B 824M 720M 664M 612M 1.15B 79.29B 7.94B 3.12B 38.85B 3.09B 3.02B 134B EV / Sales 2026 *
0.86x
EV / Sales 2027 * 0.85x
Free-Float
77.51%
Yield 2026 *
-
Yield 2027 * 0.35%
1 day-6.25%
1 week-3.85%
Current month-3.85%
1 month-3.85%
3 months-31.82%
6 months-60.32%
Current year-58.56%
1 week 0.37
Extreme 0.37
0.4
1 month 0.34
Extreme 0.34
0.42
Current year 0.3
Extreme 0.3
1.05
1 year 0.3
Extreme 0.3
1.07
3 years 0.3
Extreme 0.3
3.05
5 years 0.3
Extreme 0.3
5.54
10 years 0.3
Extreme 0.3
5.54
Manager TitleAgeSince
Chief Executive Officer - 2024-03-04
Director of Finance/CFO - 2025-10-12
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 2018-08-20
Chairman 65 2023-11-27
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
6/29/26 Expiration

Chief Executive Officer

-75,887 0.0105%
4/22/26 Fiscal year

Director

22,978 0.0032%
3/13/26 Buy

Director

8,547 0.0012%
Change 5-day change 1-year change 3-year change Capi.($)
-6.25%-3.85%-50.33%-87.42% 203M
+0.58%-3.71%+82.88%+447.60% 38.64B
+0.50%+2.06%+15.20%+33.18% 23.12B
+0.64%+2.43%-19.79%-38.73% 7.52B
-1.27%-5.69%+8.61%+99.26% 4.95B
-2.61%+0.17%+13.04%+43.21% 3B
+2.90%-8.52%-21.11%+844.64% 1.83B
-5.48%+15.20%-9.38%-65.57% 1.91B
-1.55%-0.81%+111.43%-15.35% 1.93B
-13.79%-0.44%+20.21%-27.31% 1.91B
Average -2.63%-1.79%+15.07%+123.35% 8.5B
Weighted average by Cap. -0.13%-1.90%+43.21%+231.89%

Financials

2026 *2027 *
Net sales 1.38B 962M 841M 776M 715M 1.35B 92.62B 9.28B 3.65B 45.38B 3.61B 3.53B 156B 1.42B 991M 867M 799M 736M 1.39B 95.43B 9.56B 3.76B 46.76B 3.72B 3.64B 161B
Net income -27.38M -19.11M -16.71M -15.42M -14.2M -26.78M -1.84B -184M -72.48M -902M -71.78M -70.2M -3.1B -447K -312K -273K -252K -232K -438K -30.07M -3.01M -1.18M -14.73M -1.17M -1.15M -50.73M
Net Debt 908M 634M 554M 511M 471M 888M 61B 6.11B 2.4B 29.89B 2.38B 2.33B 103B 930M 649M 567M 523M 482M 909M 62.47B 6.26B 2.46B 30.61B 2.44B 2.38B 105B
Logo Healius Limited
Healius Limited is a healthcare company. The Company's specialized pathology businesses deliver healthcare services across Australia. It provides pathology services, including specialty pathology and clinical trials. It offers medical laboratory and pathology services through a variety of specialty brands. It provides medical laboratory and pathology services across key diagnostic activities. These include anatomical pathology (histopathology and cytology), clinical pathology (biochemistry, hematology, immunology and microbiology), genomic diagnostics and veterinary pathology. Its brands include Abbot, Agilex Biolabs, Dorevitch, Gastrolab, Genomic Diagnostics, IQ Pathology, Kossard Dermatopathology, Laverty Pathology, QML Pathology, TML Pathology, Vetnostics Pathology and Western Diagnostic Pathology (WDP). These brands operate in Queensland, New South Wales (including the Australian Capital Territory), Victoria, Western Australia and Northern Territory, Tasmania, and South Australia.
Employees
5,962
Date Price Change Volume
26-07-17 A$0.3750 -6.25% 2,435,823
26-07-16 A$0.4000 +2.56% 801,999
26-07-15 A$0.3900 -2.50% 1,139,225
26-07-14 A$0.4000 +5.26% 1,494,697
26-07-13 A$0.3800 -1.30% 2,910,032
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
10
Last Close Price
0.3750AUD
Average target price
0.5032AUD
Spread / Average Target
+34.18%

Quarterly revenue - Rate of surprise